US 11406643
Targeting kinases for the treatment of cancer metastasis
granted A61KA61K31/133A61K31/137
Quick answer
US patent 11406643 (Targeting kinases for the treatment of cancer metastasis) held by The Board of Regents of the University of Texas System expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/133, A61K31/137, A61K31/18, A61K31/352